Eli Lilly has announced the success of its Phase 3b Together-PsO trial, demonstrating that combining the obesity medication Zepbound with... Read more
Category: Uncategorized
Novartis heads to FDA with Rhapsido after Phase 3 win in chronic hives sub-type
Less than six months after its inaugural approval, Novartis’ oral BTK inhibitor Rhapsido (remibrutinib) is positioning itself to become the... Read more
Eli Lilly partners with Shaquille O’Neal to support Team USA athlete recovery
Pharmaceutical giant Eli Lilly has officially teamed up with the U.S. Olympic & Paralympic Committee (USOPC) to launch and expand... Read more
Johnson & Johnson to invest $1B in new cell therapy plant in Pennsylvania
As part of its overall $55 billion U.S. investment plan, Johnson & Johnson (J&J) has announced the construction of a... Read more
Controversy surrounds President Trump’s “Most Favored Nation” drug pricing plan
President Donald Trump is pushing forward with his Most Favored Nation (MFN) plan to reduce prescription drug costs, but the... Read more
Vietnam acquires world-leading Proton therapy technology from the U.S.
As part of an international healthcare partnership, a Vietnamese general hospital system has officially signed a contract to purchase and... Read more
Market suspension of 131 cosmetic products due to substandard manufacturing facilities
National health authorities have issued an urgent nationwide recall for over 130 cosmetic items after determining that the manufacturing unit... Read more
The silent life-savers guiding through the phone during Lunar New Year
At the 115 Emergency Center in Ho Chi Minh City, the early days of the New Year are not for... Read more
Facial cleanser recalled nationwide due to undeclared ingredients
Pharmaceutical authorities have issued a nationwide recall for a popular facial cleanser line after discovering that its actual formulation did... Read more









